GoodRx Holdings, Inc. GDRX NASDAQ

GoodRx Holdings, Inc. (GDRX) has shown moderate revenue growth over the past 3 years, expanding from $767M to $797M (average +1.4%/yr). Net income reached $30M, reflecting exceptional earnings expansion at +147.8%/yr on average. The net profit margin is 3.8%, which is thin. the company was profitable in 2 out of the last 4 years tracked. The gross margin is 82.1% (high), with a -9.4pp trend over the period. With a market cap data available and MOAT composite score of 49/100, the company has a moderate competitive position.

Criteria proven by this page:

• GROWTH (73/100, Partial) — growth is present but not consistently above 5% across both metrics
• PAST (50/100, Fail) — the company has frequently reported losses. Looking at the full 10-year history, the company was profitable in 5 of 10 years — a mixed long-term record
• INCOME (30/100, Partial) — the company is profitable but margin is below 15%
• MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 57/100 with 2/7 criteria passed.